Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019;15(2):470-480.
doi: 10.1080/21645515.2018.1532248. Epub 2018 Oct 26.

Recent changes in the epidemiology of Neisseria meningitidis serogroup W across the world, current vaccination policy choices and possible future strategies

Affiliations
Review

Recent changes in the epidemiology of Neisseria meningitidis serogroup W across the world, current vaccination policy choices and possible future strategies

Robert Booy et al. Hum Vaccin Immunother. 2019.

Abstract

Invasive meningococcal disease (IMD) is a serious disease that is fatal in 5-15% and disabling in 12-20% of cases. The dynamic and unpredictable epidemiology is a particular challenge of IMD prevention. Although vaccination against meningococcal serogroups A (MenA), MenC and, more recently, MenB, are proving successful, other serogroups are emerging as major IMD causes. Recently, surges in MenW incidence occurred in South America, Europe, Australia and parts of sub-Saharan Africa, with hypervirulent strains being associated with severe IMD and higher fatality rates. This review describes global trends in MenW-IMD epidemiology over the last 5-10 years, with emphasis on the response of national/regional health authorities to increased MenW prevalence in impacted areas. Several countries (Argentina, Australia, Chile, the Netherlands and UK) have implemented reactive vaccination campaigns to reduce MenW-IMD, using MenACWY conjugate vaccines. Future vaccination programs should consider the evolving epidemiology of MenW-IMD and the most impacted age groups.

Keywords: case fatality rate; epidemiology; invasive meningococcal disease; literature review; serogroup W; vaccination strategies.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Focus on the patient section.
Figure 2.
Figure 2.
Chronological overview of changes in MenW epidemiology in the last decade (up to July 2018). IMD, invasive meningococcal disease. Note: MenW incidence rate is expressed per 100,000 population.

References

    1. World Health Organization Immunization, vaccines and biologicals. Meningococcal meningitis; Updated April 2015. [accessed 2018 Jan 15] http://www.who.int/immunization/diseases/meningitis/en/.
    1. Edmond K, Clark A, Korczak VS, Sanderson C, Griffiths UK, Rudan I.. Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10(5):317–328. doi:10.1016/s1473-3099(10)70048-7. - DOI - PubMed
    1. Borrow R, Alarcón P, Carlos J, Caugant DA, Christensen H, Debbag R, De Wals P, Echániz-Aviles G, Findlow J, Head C, et al. The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection. Expert Rev Vaccines. 2017;16(4):313–328. doi:10.1080/14760584.2017.1258308. - DOI - PubMed
    1. European Centre for Disease Prevention and Control Invasive meningococcal disease. In: ECDC. Annual epidemiological report for 2015. Stockholm: ECDC; 2017. [accessed 2018 January 10]. https://ecdc.europa.eu/sites/portal/files/documents/AER_for_2015-meningo....
    1. Centers for Disesease Control and Prevention Enhanced meningococcal disease surveillance report; 2016. [accessed 2018 January 14]. https://www.cdc.gov/meningococcal/downloads/NCIRD-EMS-Report.pdf.

Publication types

MeSH terms